Hussman Strategic Advisors, Inc. Merck & Co., Inc. Transaction History

Hussman Strategic Advisors, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$102.95 - $114.33 $205,900 - $228,660	-2,000 Reduced 32.26%	4,200 $432,000
Q2 2023 Aug 03, 2023	SELL	$108.61 - $118.38 $1.59 Million - $1.73 Million	-14,600 Reduced 70.19%	6,200 $715,000
Q4 2022 Feb 08, 2023	SELL	$87.44 - $112.11 $891,888 - $1.14 Million	-10,200 Reduced 32.9%	20,800 $2.31 Million
Q3 2022 Nov 02, 2022	BUY	$84.53 - $94.96 $2.62 Million - $2.94 Million	31,000 New	31,000 $2.67 Million
Q1 2022 May 04, 2022	SELL	$73.51 - $82.4 $764,504 - $856,960	-10,400 Closed	0 $0
Q4 2021 Jan 31, 2022	BUY	$72.28 - $90.54 $751,712 - $941,616	10,400 New	10,400 $797,000
Q2 2021 Aug 03, 2021	SELL	$70.31 - $77.77 $2.53 Million - $2.8 Million	-36,000 Closed	0 $0
Q1 2021 May 03, 2021	BUY	$68.86 - $81.11 $2.48 Million - $2.92 Million	36,000 New	36,000 $2.78 Million
Q3 2018 Oct 31, 2018	SELL	$57.69 - $67.84 $2.02 Million - $2.37 Million	-35,000 Closed	0 $0
Q2 2018 Jul 31, 2018	BUY	$50.83 - $59.72 $1.78 Million - $2.09 Million	35,000 New	35,000 $2.12 Million

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.